First use of TPM203 in various doses in patients with pemphigus vulgaris to to evaluate the safety, tolerability, and metabolism and to explore early signs of effectiveness. First use of TPM203in various doses in patients with pemphigus vulgaris to to evaluate the safety, t ...
A multi-centre, open-label, phase 1 study, Part A single ascending dose and Part B multiple dose, to evaluate the safety, tolerability and pharmacokinetics, and to explore early signs of effectiveness of induction of antigen-specific immune tolerance with TPM203 in pemphigus vulgaris patients A multi-centre, open-label, phase 1 study, Part A single ascending dose and Part B multiple dose, to ...